Replies to post #173 on BiondVax Pharmaceuticals Ltd (BVXV)

[midastouch017]

The only crucial issue now, to
make (or break) the company is
the results of the European
ongoing Phase 2b trial.
Well, Q2 2017 is not that far
away!

BTW i am very much encouraged by:

Dr. Shimon Hassin, BiondVax's COO noted, "In the past few years BiondVax focused on establishing a small scale GMP facility, one that was approved by the European Union. Our current facility laid the foundation for manufacturing quality excellence that will be implemented in the new factory."